Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 76

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 76
---
 any calendar year under all stock plans maintained by the Company may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. Optionees may pay the exercise price in cash or, with the consent of the Administrator:

with shares of common stock that the optionee already owns

by an immediate sale of shares through a broker approved by us;

through a net exercise procedure; or

<div align='center'>54</div>

• with respect to an NSO, by other methods permitted by applicable law. An optionee who exercises a SAR receives the increase in value of our common stock over the base price. The base price for SARs may not be less than 100% of the fair market value of our common stock on the grant date. The settlement value of a SAR may be paid in cash, shares of our common stock or a combination, as determined by the Administrator. Options and SARs vest as determined by the Administrator, subject to a one-year minimum vesting requirement, except that we may issue awards for up to 5% of the shares authorized for grant subject to awards under the Plan without regard to such one-year minimum vesting requirement (this limitation the “Minimum Vesting Requirement”). Subject to the Minimum Vesting Requirement, awards will generally vest over a four-year period following the date of grant. Options and SARs expire at the time determined by the Administrator but in no event more than ten years after they are granted. These awards generally expire earlier if the participant’s service terminates earlier. No participant may be granted stock options or SARs under our 2025 Plan covering more than 1,500,000 shares in any calendar year, except that a new employee may receive stock options or SARs covering up to an additional 500,000 shares in the calendar year in which employment commences. Restricted Shares and RSUs. Restricted shares and RSUs may be awarded under the 2025 Plan in return for any lawful consideration, and participants who receive restricted shares or RSUs generally are not required to pay cash for their awards. In general, these awards will be subject to vesting. Vesting may be based on length of service, the attainment of performance-based milestones or a combination of both, as determined by the Administrator, but subject to the Minimum Vesting Requirement. No participant may be granted restricted share awards or RSUs covering more than 1,500,000 shares during any calendar year, except that a new employee may receive restricted shares or RSUs covering up